Detailed Mechanism Funding and Narrative

Years of mechanism: 2011 2012 2013 2014 2015 2016 2017

Details for Mechanism ID: 13354
Country/Region: Kenya
Year: 2017
Main Partner: Kenya Episcopal Conference
Main Partner Program: NA
Organizational Type: FBO
Funding Agency: HHS/CDC
Total Funding: $0 Additional Pipeline Funding: N/A

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Care: Adult Care and Support (HBHC) $0
Care: TB/HIV (HVTB) $0
Care: Pediatric Care and Support (PDCS) $0
Testing: HIV Testing and Counseling (HVCT) $0
Biomedical Prevention: Prevention of Mother to Child Transmission (MTCT) $0
Treatment: Adult Treatment (HTXS) $0
Treatment: Pediatric Treatment (PDTX) $0
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
GEND_GBV <10, Female, Physical and/or Emotional Violence 2018 434
GEND_GBV <10, Female, Sexual Violence (Post-Rape Care) 2018 174
GEND_GBV <10, Male, Physical and/or Emotional Violence 2018 411
GEND_GBV <10, Male, Sexual Violence (Post-Rape Care) 2018 161
GEND_GBV 10-14, Female, Physical and/or Emotional Violence 2018 206
GEND_GBV 10-14, Female, Sexual Violence (Post-Rape Care) 2018 80
GEND_GBV 10-14, Male, Physical and/or Emotional Violence 2018 195
GEND_GBV 10-14, Male, Sexual Violence (Post-Rape Care) 2018 75
GEND_GBV 15-19, Female, Physical and/or Emotional Violence 2018 175
GEND_GBV 15-19, Female, Sexual Violence (Post-Rape Care) 2018 71
GEND_GBV 15-19, Male, Physical and/or Emotional Violence 2018 101
GEND_GBV 15-19, Male, Sexual Violence (Post-Rape Care) 2018 39
GEND_GBV 20-24, Female, Physical and/or Emotional Violence 2018 728
GEND_GBV 20-24, Female, Sexual Violence (Post-Rape Care) 2018 294
GEND_GBV 20-24, Male, Physical and/or Emotional Violence 2018 182
GEND_GBV 20-24, Male, Sexual Violence (Post-Rape Care) 2018 78
GEND_GBV 25-49, Female, Physical and/or Emotional Violence 2018 6,256
GEND_GBV 25-49, Female, Sexual Violence (Post-Rape Care) 2018 2,489
GEND_GBV 25-49, Male, Physical and/or Emotional Violence 2018 2,715
GEND_GBV 25-49, Male, Sexual Violence (Post-Rape Care) 2018 1,080
GEND_GBV 50+, Female, Physical and/or Emotional Violence 2018 1,206
GEND_GBV 50+, Female, Sexual Violence (Post-Rape Care) 2018 487
GEND_GBV 50+, Male, Physical and/or Emotional Violence 2018 934
GEND_GBV 50+, Male, Sexual Violence (Post-Rape Care) 2018 370
GEND_GBV By PEP service provision (related to sexual violence services provided) 2018 3,446
GEND_GBV By type of service: Physical and/or Emotional Violence (Other Post-GBV Care) 2018 22,503
GEND_GBV By type of service: Sexual Violence (Post-Rape Care) 2018 8,590
GEND_GBV Number of people receiving post-GBV care 2018 31,097
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2018 384,741
HTS_TST Service Delivery Point (Facility) ANC: 10-14, Negative 2018 75
HTS_TST Service Delivery Point (Facility) ANC: 15-19, Negative 2018 178
HTS_TST Service Delivery Point (Facility) ANC: 20-24, Negative 2018 296
HTS_TST Service Delivery Point (Facility) ANC: 25-49, Negative 2018 1,976
HTS_TST Service Delivery Point (Facility) ANC: 50+, Negative 2018 499
HTS_TST Service Delivery Point (Facility) Index: 1-9, Negative 2018 1,323
HTS_TST Service Delivery Point (Facility) Index: 10-14, Female, Negative 2018 765
HTS_TST Service Delivery Point (Facility) Index: 10-14, Male, Negative 2018 578
HTS_TST Service Delivery Point (Facility) Index: 15-19, Female, Negative 2018 801
HTS_TST Service Delivery Point (Facility) Index: 15-19, Male, Negative 2018 568
HTS_TST Service Delivery Point (Facility) Index: 20-24, Female, Negative 2018 936
HTS_TST Service Delivery Point (Facility) Index: 20-24, Male, Negative 2018 699
HTS_TST Service Delivery Point (Facility) Index: 25-49, Female, Negative 2018 1,249
HTS_TST Service Delivery Point (Facility) Index: 25-49, Male, Negative 2018 1,067
HTS_TST Service Delivery Point (Facility) Index: 50+, Female, Negative 2018 453
HTS_TST Service Delivery Point (Facility) Index: 50+, Male, Negative 2018 267
HTS_TST Service Delivery Point (Facility) Inpatient: <1, Negative 2018 215
HTS_TST Service Delivery Point (Facility) Inpatient: 1-9, Negative 2018 2,603
HTS_TST Service Delivery Point (Facility) Inpatient: 10-14, Female, Negative 2018 344
HTS_TST Service Delivery Point (Facility) Inpatient: 10-14, Male, Negative 2018 498
HTS_TST Service Delivery Point (Facility) Inpatient: 15-19, Female, Negative 2018 1,409
HTS_TST Service Delivery Point (Facility) Inpatient: 15-19, Male, Negative 2018 1,675
HTS_TST Service Delivery Point (Facility) Inpatient: 20-24, Female, Negative 2018 3,179
HTS_TST Service Delivery Point (Facility) Inpatient: 20-24, Male, Negative 2018 1,611
HTS_TST Service Delivery Point (Facility) Inpatient: 25-49, Female, Negative 2018 11,749
HTS_TST Service Delivery Point (Facility) Inpatient: 25-49, Male, Negative 2018 5,469
HTS_TST Service Delivery Point (Facility) Inpatient: 50+, Female, Negative 2018 5,306
HTS_TST Service Delivery Point (Facility) Inpatient: 50+, Male, Negative 2018 5,330
HTS_TST Service Delivery Point (Facility) Other PITC: 1-9, Negative 2018 8,278
HTS_TST Service Delivery Point (Facility) Other PITC: 10-14, Female, Negative 2018 2,897
HTS_TST Service Delivery Point (Facility) Other PITC: 10-14, Male, Negative 2018 2,544
HTS_TST Service Delivery Point (Facility) Other PITC: 15-19, Female, Negative 2018 9,795
HTS_TST Service Delivery Point (Facility) Other PITC: 15-19, Male, Negative 2018 6,848
HTS_TST Service Delivery Point (Facility) Other PITC: 20-24, Female, Negative 2018 14,850
HTS_TST Service Delivery Point (Facility) Other PITC: 20-24, Male, Negative 2018 8,237
HTS_TST Service Delivery Point (Facility) Other PITC: 25-49, Female, Negative 2018 49,190
HTS_TST Service Delivery Point (Facility) Other PITC: 25-49, Male, Negative 2018 32,141
HTS_TST Service Delivery Point (Facility) Other PITC: 50+, Female, Negative 2018 14,260
HTS_TST Service Delivery Point (Facility) Other PITC: 50+, Male, Negative 2018 13,048
HTS_TST Service Delivery Point (Facility) Pediatric : <5 Negative 2018 11,715
HTS_TST Service Delivery Point (Facility) TB: 1-9, Negative 2018 88
HTS_TST Service Delivery Point (Facility) TB: 15-19, Female, Negative 2018 15
HTS_TST Service Delivery Point (Facility) TB: 15-19, Male, Negative 2018 12
HTS_TST Service Delivery Point (Facility) TB: 20-24, Female, Negative 2018 18
HTS_TST Service Delivery Point (Facility) TB: 20-24, Male, Negative 2018 38
HTS_TST Service Delivery Point (Facility) TB: 25-49, Female, Negative 2018 169
HTS_TST Service Delivery Point (Facility) TB: 25-49, Male, Negative 2018 218
HTS_TST Service Delivery Point (Facility) TB: 50+, Female, Negative 2018 9
HTS_TST Service Delivery Point (Facility) TB: 50+, Male, Negative 2018 21
HTS_TST Service Delivery Point (Facility) VCT: 1-9, Negative 2018 1,489
HTS_TST Service Delivery Point (Facility) VCT: 10-14, Female, Negative 2018 507
HTS_TST Service Delivery Point (Facility) VCT: 10-14, Male, Negative 2018 487
HTS_TST Service Delivery Point (Facility) VCT: 15-19, Female, Negative 2018 3,566
HTS_TST Service Delivery Point (Facility) VCT: 15-19, Male, Negative 2018 2,459
HTS_TST Service Delivery Point (Facility) VCT: 20-24, Female, Negative 2018 4,761
HTS_TST Service Delivery Point (Facility) VCT: 20-24, Male, Negative 2018 3,589
HTS_TST Service Delivery Point (Facility) VCT: 25-49, Female, Negative 2018 11,150
HTS_TST Service Delivery Point (Facility) VCT: 25-49, Male, Negative 2018 7,328
HTS_TST Service Delivery Point (Facility) VCT: 50+, Female, Negative 2018 2,986
HTS_TST Service Delivery Point (Facility) VCT: 50+, Male, Negative 2018 2,392
HTS_TST Service Delivery Point Agg Age (Facility) Index: <15, Female, Negative 2018 885
HTS_TST Service Delivery Point Agg Age (Facility) Index: <15, Male, Negative 2018 767
HTS_TST Service Delivery Point Agg Age (Facility) Index: 15+, Female, Negative 2018 1,000
HTS_TST Service Delivery Point Agg Age (Facility) Index: 15+, Male, Negative 2018 763
HTS_TST Service Delivery Point by Agg Age (Facility) ANC: <15, Negative 2018 971
HTS_TST Service Delivery Point by Agg Age (Facility) ANC: 15+, Negative 2018 8,761
HTS_TST Service Delivery Point by Agg Age (Facility) Inpatient: <15, Female, Negative 2018 1,145
HTS_TST Service Delivery Point by Agg Age (Facility) Inpatient: <15, Male, Negative 2018 1,169
HTS_TST Service Delivery Point by Agg Age (Facility) Inpatient: 15+, Female, Negative 2018 7,788
HTS_TST Service Delivery Point by Agg Age (Facility) Inpatient: 15+, Male, Negative 2018 5,217
HTS_TST Service Delivery Point by Agg Age (Facility) Other PITC: <15, Female, Negative 2018 4,665
HTS_TST Service Delivery Point by Agg Age (Facility) Other PITC: <15, Male, Negative 2018 4,392
HTS_TST Service Delivery Point by Agg Age (Facility) Other PITC: 15+, Female, Negative 2018 32,406
HTS_TST Service Delivery Point by Agg Age (Facility) Other PITC: 15+, Male, Negative 2018 22,607
HTS_TST Service Delivery Point by Agg Age (Facility) TB: <15, Female, Negative 2018 21
HTS_TST Service Delivery Point by Agg Age (Facility) TB: <15, Male, Negative 2018 14
HTS_TST Service Delivery Point by Agg Age (Facility) TB: 15+, Female, Negative 2018 89
HTS_TST Service Delivery Point by Agg Age (Facility) TB: 15+, Male, Negative 2018 98
HTS_TST Service Delivery Point by Agg Age (Facility) VCT: <15, Female, Negative 2018 771
HTS_TST Service Delivery Point by Agg Age (Facility) VCT: <15, Male, Negative 2018 754
HTS_TST Service Delivery Point by Agg Age (Facility) VCT: 15+, Female, Negative 2018 7,724
HTS_TST Service Delivery Point by Agg Age (Facility) VCT: 15+, Male, Negative 2018 5,272
HTS_TST Sum of Test Result disaggregates 2018 11,265
HTS_TST_POS By Test Result: Positive 2018 11,265
HTS_TST_POS Service Delivery Point (Facility) Index: 1-9, Positive 2018 14
HTS_TST_POS Service Delivery Point (Facility) Index: 10-14, Female, Positive 2018 10
HTS_TST_POS Service Delivery Point (Facility) Index: 10-14, Male, Positive 2018 4
HTS_TST_POS Service Delivery Point (Facility) Index: 15-19, Female, Positive 2018 3
HTS_TST_POS Service Delivery Point (Facility) Index: 15-19, Male, Positive 2018 2
HTS_TST_POS Service Delivery Point (Facility) Index: 20-24, Female, Positive 2018 12
HTS_TST_POS Service Delivery Point (Facility) Index: 20-24, Male, Positive 2018 6
HTS_TST_POS Service Delivery Point (Facility) Index: 25-49, Female, Positive 2018 56
HTS_TST_POS Service Delivery Point (Facility) Index: 25-49, Male, Positive 2018 39
HTS_TST_POS Service Delivery Point (Facility) Index: 50+, Female, Positive 2018 4
HTS_TST_POS Service Delivery Point (Facility) Index: 50+, Male, Positive 2018 3
HTS_TST_POS Service Delivery Point (Facility) Inpatient: <1, Positive 2018 1
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 1-9, Positive 2018 7
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 10-14, Female, Positive 2018 5
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 10-14, Male, Positive 2018 1
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 15-19, Female, Positive 2018 7
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 15-19, Male, Positive 2018 11
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 20-24, Female, Positive 2018 34
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 20-24, Male, Positive 2018 24
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 25-49, Female, Positive 2018 175
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 25-49, Male, Positive 2018 117
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 50+, Female, Positive 2018 51
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 50+, Male, Positive 2018 27
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 1-9, Positive 2018 45
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 10-14, Female, Positive 2018 27
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 10-14, Male, Positive 2018 20
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 15-19, Female, Positive 2018 181
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 15-19, Male, Positive 2018 160
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 20-24, Female, Positive 2018 601
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 20-24, Male, Positive 2018 486
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 25-49, Female, Positive 2018 1,950
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 25-49, Male, Positive 2018 1,545
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 50+, Female, Positive 2018 400
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 50+, Male, Positive 2018 327
HTS_TST_POS Service Delivery Point (Facility) Pediatric : <5 Positive 2018 31
HTS_TST_POS Service Delivery Point (Facility) TB: 1-9, Positive 2018 10
HTS_TST_POS Service Delivery Point (Facility) TB: 15-19, Female, Positive 2018 3
HTS_TST_POS Service Delivery Point (Facility) TB: 15-19, Male, Positive 2018 7
HTS_TST_POS Service Delivery Point (Facility) TB: 20-24, Female, Positive 2018 10
HTS_TST_POS Service Delivery Point (Facility) TB: 20-24, Male, Positive 2018 17
HTS_TST_POS Service Delivery Point (Facility) TB: 25-49, Female, Positive 2018 122
HTS_TST_POS Service Delivery Point (Facility) TB: 25-49, Male, Positive 2018 102
HTS_TST_POS Service Delivery Point (Facility) TB: 50+, Male, Positive 2018 6
HTS_TST_POS Service Delivery Point (Facility) VCT: 1-9, Positive 2018 28
HTS_TST_POS Service Delivery Point (Facility) VCT: 10-14, Female, Positive 2018 3
HTS_TST_POS Service Delivery Point (Facility) VCT: 10-14, Male, Positive 2018 8
HTS_TST_POS Service Delivery Point (Facility) VCT: 15-19, Female, Positive 2018 46
HTS_TST_POS Service Delivery Point (Facility) VCT: 15-19, Male, Positive 2018 19
HTS_TST_POS Service Delivery Point (Facility) VCT: 20-24, Female, Positive 2018 166
HTS_TST_POS Service Delivery Point (Facility) VCT: 20-24, Male, Positive 2018 84
HTS_TST_POS Service Delivery Point (Facility) VCT: 25-49, Female, Positive 2018 767
HTS_TST_POS Service Delivery Point (Facility) VCT: 25-49, Male, Positive 2018 422
HTS_TST_POS Service Delivery Point (Facility) VCT: 50+, Female, Positive 2018 47
HTS_TST_POS Service Delivery Point (Facility) VCT: 50+, Male, Positive 2018 57
HTS_TST_POS Service Delivery Point Agg Age (Facility) Index: <15, Female, Positive 2018 11
HTS_TST_POS Service Delivery Point Agg Age (Facility) Index: <15, Male, Positive 2018 5
HTS_TST_POS Service Delivery Point Agg Age (Facility) Index: 15+, Female, Positive 2018 33
HTS_TST_POS Service Delivery Point Agg Age (Facility) Index: 15+, Male, Positive 2018 16
HTS_TST_POS Service Delivery Point by Agg Age (Facility) Inpatient: <15, Female, Positive 2018 13
HTS_TST_POS Service Delivery Point by Agg Age (Facility) Inpatient: <15, Male, Positive 2018 7
HTS_TST_POS Service Delivery Point by Agg Age (Facility) Inpatient: 15+, Female, Positive 2018 189
HTS_TST_POS Service Delivery Point by Agg Age (Facility) Inpatient: 15+, Male, Positive 2018 141
HTS_TST_POS Service Delivery Point by Agg Age (Facility) Other PITC: <15, Female, Positive 2018 73
HTS_TST_POS Service Delivery Point by Agg Age (Facility) Other PITC: <15, Male, Positive 2018 52
HTS_TST_POS Service Delivery Point by Agg Age (Facility) Other PITC: 15+, Female, Positive 2018 967
HTS_TST_POS Service Delivery Point by Agg Age (Facility) Other PITC: 15+, Male, Positive 2018 739
HTS_TST_POS Service Delivery Point by Agg Age (Facility) TB: <15, Female, Positive 2018 8
HTS_TST_POS Service Delivery Point by Agg Age (Facility) TB: <15, Male, Positive 2018 3
HTS_TST_POS Service Delivery Point by Agg Age (Facility) TB: 15+, Female, Positive 2018 61
HTS_TST_POS Service Delivery Point by Agg Age (Facility) TB: 15+, Male, Positive 2018 56
HTS_TST_POS Service Delivery Point by Agg Age (Facility) VCT: <15, Female, Positive 2018 16
HTS_TST_POS Service Delivery Point by Agg Age (Facility) VCT: <15, Male, Positive 2018 15
HTS_TST_POS Service Delivery Point by Agg Age (Facility) VCT: 15+, Female, Positive 2018 335
HTS_TST_POS Service Delivery Point by Agg Age (Facility) VCT: 15+, Male, Positive 2018 195
PMTCT_ART Already on ART at beginning of current pregnancy 2018 1,589
PMTCT_ART New on ART 2018 747
PMTCT_ART Number of HIV-positive pregnant women who received ART to reduce risk of mother-to-child-transmission (MTCT) during pregnancy 2018 2,336
PMTCT_ART Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2018 14,373
PMTCT_EID Number of infants who had a virologic HIV test within 12 months of birth during the reporting period 2018 2,341
PMTCT_EID Number of infants with a negative virological test result between 2 and 12 months of birth 2018 588
PMTCT_EID Number of infants with a negative virological test result within 2 months of birth 2018 1,687
PMTCT_EID Number of infants with a positive virological test result between 2 and 12 months of birth 2018 19
PMTCT_EID Number of infants with a positive virological test result within 2 months of birth 2018 47
PMTCT_STAT By Age (Numerator): 10-14 2018 210
PMTCT_STAT By Age (Numerator): 15-19 2018 540
PMTCT_STAT By Age (Numerator): 20-24 2018 1,399
PMTCT_STAT By Age (Numerator): 25-49 2018 9,742
PMTCT_STAT By Age (Numerator): 50+ 2018 2,482
PMTCT_STAT By Number of known positives: 10-14 2018 30
PMTCT_STAT By Number of known positives: 15-19 2018 65
PMTCT_STAT By Number of known positives: 20-24 2018 234
PMTCT_STAT By Number of known positives: 25-49 2018 1,015
PMTCT_STAT By Number of known positives: 50+ 2018 241
PMTCT_STAT By Number of new negative: 10-14 2018 170
PMTCT_STAT By Number of new negative: 15-19 2018 1,162
PMTCT_STAT By Number of new negative: 20-24 2018 2,143
PMTCT_STAT By Number of new negative: 25-49 2018 6,815
PMTCT_STAT By Number of new negative: 50+ 2018 1,637
PMTCT_STAT By Number of new positives: 10-14 2018 9
PMTCT_STAT By Number of new positives: 15-19 2018 32
PMTCT_STAT By Number of new positives: 20-24 2018 124
PMTCT_STAT By Number of new positives: 25-49 2018 577
PMTCT_STAT By Number of new positives: 50+ 2018 119
PMTCT_STAT Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2018 14,373
PMTCT_STAT_den By Age (Denominator): <10 2018 3
PMTCT_STAT_den By Age (Denominator): <15-19 2018 540
PMTCT_STAT_den By Age (Denominator): 10-14 2018 210
PMTCT_STAT_den By Age (Denominator): 20-24 2018 1,396
PMTCT_STAT_den By Age (Denominator): 25-49 2018 9,742
PMTCT_STAT_den By Age (Denominator): 50+ 2018 2,482
TB_ART Aggregated Age/Sex: Female <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2018 101
TB_ART Aggregated Age/Sex: Female 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2018 635
TB_ART Aggregated Age/Sex: Male <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2018 50
TB_ART Aggregated Age/Sex: Male 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2018 359
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period 2018 1,155
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period 2018 1,155
TB_ART_den Aggregated Age/Sex: Female <15 (Denominator: The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period) 2018 102
TB_ART_den Aggregated Age/Sex: Female 15+ (Denominator: The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period) 2018 641
TB_ART_den Aggregated Age/Sex: Male <15 (Denominator: The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period) 2018 50
TB_ART_den Aggregated Age/Sex: Male 15+ (Denominator: The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period) 2018 362
TB_STAT Aggregated Age/Sex: Female <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2018 161
TB_STAT Aggregated Age/Sex: Female 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2018 884
TB_STAT Aggregated Age/Sex: Male <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2018 80
TB_STAT Aggregated Age/Sex: Male 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2018 514
TB_STAT Number of registered new and relapsed TB cases with documented HIV status, during the reporting period 2018 1,639
TB_STAT Total number of registered new and relapsed TB cases, during the reporting period 2018 1,687
TB_STAT_den Aggregated Age/Sex: Female <15 (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2018 165
TB_STAT_den Aggregated Age/Sex: Female 15+ (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2018 922
TB_STAT_den Aggregated Age/Sex: Male <15 (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2018 76
TB_STAT_den Aggregated Age/Sex: Male 15+ (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2018 524
TX_CURR Age/Sex: <1 2018 30
TX_CURR Age/Sex: <1-9 2018 1,504
TX_CURR Age/Sex: 10-14 Female 2018 1,385
TX_CURR Age/Sex: 10-14 Male 2018 707
TX_CURR Age/Sex: 15-19 Female 2018 682
TX_CURR Age/Sex: 15-19 Male 2018 549
TX_CURR Age/Sex: 20-24 Female 2018 2,848
TX_CURR Age/Sex: 20-24 Male 2018 1,688
TX_CURR Age/Sex: 25-49 Female 2018 24,191
TX_CURR Age/Sex: 25-49 Male 2018 11,077
TX_CURR Age/Sex: 50+ Female 2018 6,424
TX_CURR Age/Sex: 50+ Male 2018 3,892
TX_CURR Aggregated Age/Sex: <15 Female 2018 1,509
TX_CURR Aggregated Age/Sex: <15 Male 2018 1,078
TX_CURR Aggregated Age/Sex: 15+ Female 2018 19,498
TX_CURR Aggregated Age/Sex: 15+ Male 2018 13,516
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2018 90,578
TX_CURR Sum of age/sex disaggregates 2018 1,231
TX_CURR Sum of Aggregated Age/Sex <15 2018 2,587
TX_CURR Sum of Aggregated Age/Sex 15+ 2018 33,014
TX_CURR Sum of Aggregated Age/Sex disaggregates 2018 35,601
TX_NEW Aggregated Grouping by Age/Sex: <15 Female 2018 224
TX_NEW Aggregated Grouping by Age/Sex: <15 Male 2018 135
TX_NEW Aggregated Grouping by Age/Sex: 15+ Female 2018 2,501
TX_NEW Aggregated Grouping by Age/Sex: 15+ Male 2018 1,683
TX_NEW Breastfeeding status 2018 73
TX_NEW By Age/Sex: <1 2018 2
TX_NEW By Age/Sex: 1-9 2018 398
TX_NEW By Age/Sex: 10-14 Female 2018 57
TX_NEW By Age/Sex: 10-14 Male 2018 46
TX_NEW By Age/Sex: 15-19 Female 2018 207
TX_NEW By Age/Sex: 15-19 Male 2018 129
TX_NEW By Age/Sex: 20-24 Female 2018 922
TX_NEW By Age/Sex: 20-24 Male 2018 355
TX_NEW By Age/Sex: 25-49 Female 2018 6,843
TX_NEW By Age/Sex: 25-49 Male 2018 3,102
TX_NEW By Age/Sex: 50+ Female 2018 1,473
TX_NEW By Age/Sex: 50+ Male 2018 1,185
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2018 19,262
TX_NEW Pregnancy status 2018 677
TX_NEW Sum of Age/Sex disaggregates 2018 14,319
TX_NEW Sum of Aggregated Age/Sex disaggregates 2018 4,543
TX_PVLS Breastfeeding, Undocumented Test Indication 2018 1
TX_PVLS Breastfeeding, Undocumented Test Indication 2018 1
TX_PVLS Number of adult and pediatric ART patients with a viral load result documented in the patient medical record and /or laboratory records in the past 12 months 2018 90,590
TX_PVLS Number of adults and pediatric patients on ART with suppressed viral load results (<1,000 copies/ml) documented in the medical records and /or supporting laboratory results within the past 12 months 2018 80,939
TX_PVLS Numerator: Aggregate Age/Sex by Indication: <15 Female Routine 2018 3,228
TX_PVLS Numerator: Aggregate Age/Sex by Indication: <15 Female Targeted 2018 345
TX_PVLS Numerator: Aggregate Age/Sex by Indication: <15 Male Routine 2018 1,946
TX_PVLS Numerator: Aggregate Age/Sex by Indication: <15 Male Targeted 2018 252
TX_PVLS Numerator: Aggregate Age/Sex by Indication: 15+ Female Routine 2018 44,583
TX_PVLS Numerator: Aggregate Age/Sex by Indication: 15+ Female Targeted 2018 3,242
TX_PVLS Numerator: Aggregate Age/Sex by Indication: 15+ Male Routine 2018 25,510
TX_PVLS Numerator: Aggregate Age/Sex by Indication: 15+ Male Targeted 2018 1,815
TX_PVLS Numerator: Indication: Routine 2018 75,267
TX_PVLS Numerator: Indication: Targeted 2018 5,672
TX_PVLS Numerator: Preg/BF by Indication: Breastfeeding Routine 2018 168
TX_PVLS Numerator: Preg/BF by Indication: Breastfeeding Targeted 2018 6
TX_PVLS Numerator: Preg/BF by Indication: Pregnant Routine 2018 1,272
TX_PVLS Numerator: Preg/BF by Indication: Pregnant Targeted 2018 80
TX_PVLS Unknown Age, Targeted, Female 2018 9
TX_PVLS Unknown Age, Targeted, Female 2018 12
TX_PVLS Unknown Age, Targeted, Male 2018 9
TX_PVLS Unknown Age, Targeted, Male 2018 11
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Female Routine 2018 3,612
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Female Targeted 2018 384
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Male Routine 2018 2,170
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Male Targeted 2018 279
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Female Routine 2018 49,901
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Female Targeted 2018 3,635
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Male Routine 2018 28,562
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Male Targeted 2018 2,023
TX_PVLS_den Denominator: Indication: Routine 2018 84,245
TX_PVLS_den Denominator: Indication: Targeted 2018 6,344
TX_PVLS_den Denominator: Preg/BF by Indication: Breastfeeding Routine 2018 170
TX_PVLS_den Denominator: Preg/BF by Indication: Breastfeeding Targeted 2018 8
TX_PVLS_den Denominator: Preg/BF by Indication: Pregnant Routine 2018 1,356
TX_PVLS_den Denominator: Preg/BF by Indication: Pregnant Targeted 2018 85
TX_RET Aggregated Age/Sex: <15 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 495
TX_RET Aggregated Age/Sex: <15 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 318
TX_RET Aggregated Age/Sex: 15+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 11,046
TX_RET Aggregated Age/Sex: 15+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 6,442
TX_RET Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2018 18,301
TX_RET Numerator by Status: Breastfeeding 2018 67
TX_RET Numerator by Status: Pregnant 2018 646
TX_RET Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2018 19,264
TX_RET_den Aggregated Age/Sex: <15 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 584
TX_RET_den Aggregated Age/Sex: <15 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 379
TX_RET_den Aggregated Age/Sex: 15+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 11,605
TX_RET_den Aggregated Age/Sex: 15+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 6,696
TX_RET_den Denominator by Status: Breastfeeding 2018 72
TX_RET_den Denominator by Status: Pregnant 2018 663
TX_TB Number of ART patients who were screened for TB at least once during the reporting period 2018 86,335
TX_TB Number of ART patients who were started on TB treatment during the reporting period 2018 461
TX_TB Numerator: By Aggregated Age/Sex: <15, Female 2018 33
TX_TB Numerator: By Aggregated Age/Sex: <15, Male 2018 13
TX_TB Numerator: By Aggregated Age/Sex: 15+, Female 2018 267
TX_TB Numerator: By Aggregated Age/Sex: 15+, Male 2018 148
TX_TB_den Denominator: By Aggregated Age/Sex: <15, Female 2018 3,665
TX_TB_den Denominator: By Aggregated Age/Sex: <15, Male 2018 3,030
TX_TB_den Denominator: By Aggregated Age/Sex:15+, Female 2018 50,452
TX_TB_den Denominator: By Aggregated Age/Sex:15+, Male 2018 29,188
TX_TB_den Denominator: By Diagnostic Test [Subdisagg of Specimen Sent]: Gene Xpert MTB / R if Assay 2018 9,964
TX_TB_den Denominator: By Diagnostic Test [Subdisagg of Specimen Sent]: Other (No Xpert) 2018 859
TX_TB_den Denominator: By Diagnostic Test [Subdisagg of Specimen Sent]: Smear Only 2018 6,444
TX_TB_den Denominator: By Screen Result: Negative 2018 69,067
TX_TB_den Denominator: By Screen Result: Positive 2018 17,268
TX_TB_den Denominator: Number of ART patients who had a specimen sent for bacteriologic diagnosis of active TB disease 2018 17,254